For thousands of years, tissue regeneration has been a topic of interest among the scientific world. Regenerative medicine is a foremost advancement in the medical treatment which is used to replace or regenerate human tissues and organs by using stem cell technology and tissue engineering.

Cancer stem cells are also known to be responsible for tumor development, metastasis, and degeneration after conventional therapies. Emergent therapeutic strategies in cancer have been focusing to stimulate an immune response against tumors by using mAbs and since the inception of mAbs as cancer fighters, researchers are identifying and characterizing the stem cells of different tumor types.

Since mAbs should be able to facilitate earlier diagnosis by targeting specific antigens transformed in cancer stem cells through molecular imaging which enables efficient destruction of tumor initiating cells, and they improve clinical outcome for patients undergoing treatment.

To gain more knowledge on this, please join in with Prof. Jaroslav Michalek MD Ph.D., Cellthera Clinic, Brno, Czech Republic